Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Tyrosine Kinase Inhibitors
>>
Phase 3
1
2
3
4
5
6
7
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
13
26
39
52
65
78
91
104
117
130
Recentin
(cediranib) / AstraZeneca
Nerlynx
(neratinib) / Puma
Tukysa
(tucatinib) / Pfizer
famitinib
(SHR 1020) / Jiangsu Hengrui Pharma
Tavalisse
(fostamatinib) / Rigel, Grifols
Rydapt
(midostaurin) / Novartis
dovitinib
(TKI258) / Novartis, Oncoheroes
itacitinib
(INCB039110) / Incyte
Xospata
(gilteritinib) / Astellas
Kinaction
(masitinib) / AB Science
tivantinib
(ARQ 197) / Daiichi Sankyo, Kyowa Kirin, Merck (MSD)
Orpathys
(savolitinib) / AstraZeneca, Hutchmed
Vonjo
(pacritinib) / SOBI
Litfulo
(ritlecitinib) / Pfizer
Leclaza
(lazertinib) / J&J
vatalanib
(PTK787) / Novartis, Bayer
ganetespib
(ADX-1612) / Aldeyra
sitravatinib
(MGCD516) / BeiGene
Balversa
(erdafitinib) / J&J
Jaypirca
(pirtobrutinib) / Eli Lilly
Vanflyta
(quizartinib) / Daiichi Sankyo
Fotivda
(tivozanib) / Kyowa Kirin, Jazz, LG Chem
saracatinib
(AZD0530) / AstraZeneca
Awiqli
(insulin icodec) / Novo Nordisk
Inrebic
(fedratinib) / BMS
Rybrevant
(amivantamab-vmjw) / J&J
jaktinib
/ Suzhou Zelgen
Smyraf
(peficitinib) / Astellas, Maruho
trebananib
(AMG 386) / Amgen
defactinib
(VS-6063) / Verastem
Herceptin Hylecta
(trastuzumab/hyaluronidase-oysk) / Roche, Halozyme
Truseltiq
(infigratinib) / BridgeBio, Pfizer, Xediton Pharma
ivarmacitinib
(SHR0302) / Jiangsu Hengrui Pharma, Arcutis
semaxanib
(SU5416) / Pfizer
ganitumab
(AMG 479) / Takeda, ImmunityBio
ivonescimab
(AK112) / Akesobio, Summit Therap
trastuzumab rezetecan
(SHR-A1811) / Jiangsu Hengrui Pharma
lucitanib
(E 3810) / Clovis, Servier
brivanib alaninate
(BMS-582664) / ZAI Lab
insulin peglispro
(LY2605541) / Eli Lilly
linsitinib
(ASP7487) / Sling Therap
remibrutinib
(LOU064) / Novartis
carotuximab IV
(ENV-105) / Kairos Pharma
motesanib
(AMG 706) / Takeda
Portrazza
(necitumumab) / Eli Lilly
dalotuzumab
(MK 0646) / Merck (MSD), Pierre Fabre
fexagratinib
(ABSK091) / Abbisko
figitumumab
(CP-751,871) / Novartis
Fumena
(vorolanib) / Tyrogenex, Betta Pharma
Lartruvo
(olaratumab) / Eli Lilly
1
2
3
4
5
6
7
»
